![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
CARAVEL: evaluation of real-world antiviral effectiveness and sustainability of the 2-drug regimen
Dolutegravir/Lamivudine FDC in treatment-naïve adults and pre-treated adults who are virologicaly suppressed, in routine clinical care, in France. One-year interim analysis results.
|
|
|
EACS 2023 Oct 19
P. Philibert1, C. Charpentier2, N. Naguleswaran3, C. Philippe3, L. Roustand4, C. Vouillot5, L. Hocqueloux6
1Hôpital Européen, Marseille, France, 2Hôpital Bichat-Claude Bernard, Paris, France, 3QUALEES, Paris, France, 4GSK, Rueil-Malmaison, France, 5ViiV Healthcare, Rueil-Malmaison, France, 6CHU, Orléans, France
![1023231](../images/102323/102323-25/1023231.gif)
![1023232](../images/102323/102323-25/1023232.gif)
![1023233](../images/102323/102323-25/1023233.gif)
![1023234](../images/102323/102323-25/1023234.gif)
![1023235](../images/102323/102323-25/1023235.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|